Xenon Pharmaceuticals Inc.
XENE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001582313
In the last 90 days, Xenon Pharmaceuticals Inc. insiders filed 2 open-market purchases and 2 sales; 315 institutions reported holding it in 13F filings for Q2 2026, worth $6.10B in total; Duquesne Family Office is the only superinvestor holding it.
Q2 2023 vs. Q1 2023
How the institutions holding Xenon Pharmaceuticals Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 163 | 1 | 175 | +13 |
| Shares | 61.1M | 283 | 61.3M | +174.4K (+0.3%) |
| Value | $2.19B | $10.0K | $2.36B | +$174.7M (+8.0%) |
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (33)
Institutions that held Xenon Pharmaceuticals Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (20)
Institutions that held Xenon Pharmaceuticals Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Norges Bank | 365,830 | $13.1M |
| ExodusPoint Capital Management, LP | 302,980 | $10.8M |
| Nomura Holdings Inc | 221,095 | $7.91M |
| Weiss Multi-Strategy Advisers LLC | 54,140 | $1.94M |
| Moore Capital Management, LP | 34,417 | $1.23M |
| Tudor Investment Corp Et Al | 29,908 | $1.07M |
| Kynam Capital Management, LP | 28,696 | $1.03M |
| Gsa Capital Partners LLP | 18,562 | $664.0K |
| Oppenheimer & Co Inc | 12,615 | $451.5K |
| Bayesian Capital Management, LP | 10,900 | $390.1K |
| Virginia Retirement Systems Et Al | 10,300 | $368.6K |
| American Century Companies Inc | 9,474 | $337.4K |
| Susquehanna Fundamental Investments, LLC | 8,400 | $300.6K |
| Kapitalo Investimentos Ltda | 3,612 | $129.3K |
| Values First Advisors, Inc. | 3,498 | $125.2K |
| Dark Forest Capital Management LP | 2,455 | $87.9K |
| Aquatic Capital Management LLC | 2,000 | $72.0K |
| Cubist Systematic Strategies, LLC | 1,955 | $70.0K |
| Belpointe Asset Management LLC | 70 | $2.50K |
| Mirabella Financial Services LLP | 11,802 | – |
Not filed for Q2 2023 yet (1)
Institutions that held Xenon Pharmaceuticals Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Householder Group Estate & Retirement Specialist, LLC | 283 | $10.0K |